Skip to main content
Mehmet Hepgur, MD, Oncology, Deerfield Beach, FL

MehmetF GokhamHepgurMD

Oncology Deerfield Beach, FL

Gastrointestinal Cancer, Genitourinary Oncology, Hematologic Oncology

Attending Hematologist/Oncologist

Dr. Hepgur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hepgur's full profile

Already have an account?

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2011 - 2014
  • University at Buffalo
    University at BuffaloResidency, Internal Medicine, 2008 - 2011
  • Istanbul University Fom
    Istanbul University FomClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2014 - 2026
  • CA State Medical License
    CA State Medical License 2010 - 2024
  • TN State Medical License
    TN State Medical License 2014 - 2019
  • AL State Medical License
    AL State Medical License Active through 2006
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Best Research Presentation Award USC Keck School of Medicine, 2014
  • Conquer Cancer Foundation Merit Award American Society of Medical Oncology, 2013

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of Skull Thickness and Insertion Torque at the Halo Pin Insertion Areas in the Elderly  
    Ebraheim N, Hepgur M, The Spine Journal
  • Solitary Splenic Metastasis from Primary Non Small Cell Carcinoma of the Lung  
    Hepgur M Noor M DePlato A, International Journal of Hematology and Oncology

Abstracts/Posters

  • Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC)
    Mehmet Faith Hepgur, Tanya B. Dorff, Jie Cai, Mary Reed, Betty Chan, David I. Quinn;, J Clin Oncol 33, 2015 (suppl 7; abstr 181)
  • Identification of biological and inflammatory markers for predicting clinical responses to Sipuleucel-T in mCRPC.
    Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
  • Clinical and biological factors for immune response to Sipuleucel-T for metastatic castrate resistant prostate cancer.
    Hepgur M, Dorff TB, Cai J, Pinski JK, Reed M, Luther M, Chan M, Quinn DI., ASCO GU Cancers Symposium, 2/2014
  • Join now to see all

Press Mentions

  • Broward Health and Voluntis Launch a New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast Cancer
    Broward Health and Voluntis Launch a New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast CancerMarch 18th, 2021

Committees

  • Peer-reviewer, OncoTargets and Therapy 2014 - Present
  • Peer-reviewer, ImmunoTargets and Therapy 2014 - Present

Research History

  • Research AssociateRoswell Park Cancer Institute Division of Bone Marrow Transplantation2009 - 2009

Other Languages

  • Turkish